53PImmune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme. (17th December 2018) - Baldini, E; Lunghi, A; Cortesi, E; Turci, D; Garassino, M C; Stati, V; Ardizzoni, A; Ricciuti, B; Frassoldati, A; Romano, G; Illiano, A; Verderame, F; et al.